Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK136520-03
Morning Light Treatment for Inflammatory Bowel Disease: A Pilot Clinical Trial
Recipient
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Award Amount
$312,000.00
Ceiling
$312,000.00
Awarded
July 16, 2025
Identifier
5R01DK136520-03
This award funds a pilot clinical trial to evaluate morning light treatment for IBD, aiming to develop a non-drug adjunctive therapy. The project runs from September 2023 to December 2026 and is supported by the National Institute of Diabetes and Digestive and Kidney Diseases.
Description
A clinical trial testing morning light treatment as a non-pharmacological adjunctive treatment for inflammatory bowel disease (IBD). The project includes patient-reported outcomes, clinician-rated disease severity, and biomarkers.